Abstract
Platelet-activating factor (PAF) is a phospholipid mediator of long-term potentiation, synaptic plasticity and memory formation as well as of the development of brain damage. In brain, PAF is synthesized by two distinct pathways but their relative contribution to its productions, in various physiological and pathological conditions, is not established. We have further investigated on the properties of the two enzymes that catalyze the last step of the de novo or remodeling pathways in rat brain microsomes, PAF-synthesizing phosphocholinetransferase (PAF-PCT) and lysoPAF acetyltransferase (lysoPAF-AT), respectively. The latter enzyme is fully active at μM Ca2+ concentration, inhibited by MgATP and activated by phosphorylation. Because the reversibility of the reaction catalyzed by PAF-PCT, its direction depends on the ratio [CDP-choline]/[CMP] which is related to the energy charge of the cell. These and other properties indicate that the de novo pathway should mainly contribute to PAF synthesis for maintaining its basal levels under physiological conditions. The remodeling pathway should be more involved in the production of PAF during ischemia. During reperfusion, the overproduction of PAF should be the result of the concomitant activation of both pathways.
Similar content being viewed by others
REFERENCES
Goracci, G. 1990. PAF in the nervous system: biochemistry and pathophysiology. Pages 377-388, in Kriaglstein, J. and Oberpichler, H. (eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
Baker, R. R. 1995. Enzymes of platelet activating factor synthesis in brain. Neurochem. Res. 20:1345-1351.
Bazan, N. G. 1998. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Progress in Brain Research 118:281-291.
Bussolino, F., Gremo, F., Tetra, C., Pescarmona, G. P., and Camussi, G. 1986. Production of platelet-activating factor by chick retina. J. Biol. Chem. 261:16502-16508.
Sogos, V., Bussolino, F., Pilia, E., Torelli, S., and Gremo, F. 1990. Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture. J. Neurosci. Res. 27: 706-711.
Nogami, K., Hirashima, Y., Endo, S., and Takaku, A. 1997. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures. Brain Res. 754:72-78.
Bussolino, F., Tessari, F., Turrini, F., Braquet, P., Camussi, G., Prosdocimi, M., and Bosia, A. 1988. Platelet activating factor induces dopamine release in PC-12 cell line. American Journal of Physiology 255:C559-C565.
Clark, G. D., Happel, L. T., Zorumski, C. F., and Bazan, N. G. 1992. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9:1211-1216.
Kato, K., Clark, G. D., Bazan, N. G., and Zorumski, C. F. 1994. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179.
Wieraszko, A., Gang, L., Kornecki, E., Hogan, M. V., and Ehrlich, Y. H. 1993. Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 10:553-557.
Grassi, S., Francescangeli, E., Goracci, G., and Pettorossi, V. E. 1998. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. J. Neurophysiol. 79: 3266-3271.
Grassi, S., Francescangeli, E., Goracci, G., and Pettorossi, V. E. 1999. Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. Neuroscience 94:549-559.
Domingo, M. T., Spinnewyn, B., Chabrier, P. E., and Braquet, P. 1988. Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem. Biophys. Res. Commun. 151: 730-736.
Bito, H., Honda, Z., Nakamura, M., and Shimizu, T. 1994. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221:211-218.
Kornecki, E. and Ehrlich, Y. H. 1988. Neuroregulatory and neuropathological actions of the ether-phospholipid plateletactivating factor. Science 240:1792-1794.
Francescangeli, E., Lang, D., Dreyfus, H., Boila, A., Freysz, L., and Goracci, G. 1977. Activities of enzymes involved in the metabolism of platelet-activating factor in neural cell cultures during proliferation and differentiation. Neurochem. Res. 22: 1299-1307.
Albrecht, U., Abu-Issa, R., Ratz, B., Hattori, M., Aoki, J., Arai, H., Inoue, K. and Eichele, G. 1996. Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor. Dev. Biol. 180:579-593.
Kumar, R., Harvey, S. A., Kester, M., Hanahan, D. J., and Olson, M. S. 1988. Production and effects of platelet-activating factor in the rat brain. Biochim. Biophys. Acta 963:375-383.
Domingo, M. T., Spinnewyn, B., Chabrier, P. E., and Braquet, P. 1994. Changes in [3H]PAF binding and PAF concentrations in gerbil brain after bilateral common carotid artery occlusion: a quantitative autoradiographic study. Brain Res. 640:268-276.
Nishida, K. and Markey, S. P. 1996. Platelet-activating factor in brain regions after transient ischemia in gerbils. Stroke 27:514-518.
Birkle, D. L., Kurian, P., Braquet, P., and Bazan, N. G. 1988. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J. Neurochem. 51: 1900-1905.
Panetta, T., Marcheselli, V. L., Braquet, P., Spinnewyn, B., and Bazan, N. G. 1987. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem. Biophys. Res. Commun. 149:580-587.
Kornecki, E. and Ehrlich, Y. H. 1991. Calcium Ion Mobilization in Neuronal cells Induced by PAF. Lipids 26:1243-1246.
Mukherjee, P. K., Decoster, M. A., Campbell, F. Z., Davis, R. J., and Bazan, N. G. 1999. Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. J. Biol. Chem. 274:6493-6498.
Perry, S. W., Hamilton, J. A., Tjoelker, L. W., Dbaibo, G., Dzenko, K. A., Epstein, L. G., Hannun, Y., Whittaker, J. S., Dewhurst, S., and Gelbard, H. A. 1998. Platelet-activating factor receptor activation-An initiator step in HIV-1 neuropathogenesis. J. Biol. Chem. 273:17660-17664.
Nishida, K., Markey, S. P., Kustova, Y., Morse, H. C., Skolnick, P., Basile, A. S., and Sei, Y. 1996. Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated. J. Neurochem. 66: 433-435.
Hershkowitz, M. and Adunsky, A. 1996. Binding of plateletactivating factor to platelets of Alzheimer' disease and multiinfarct dementia patients. Neurobiology of Aging 17:865-868.
Callea, L., Arese, M., Orlandini, A., Bargnani, C., Priori, A., and Bussolino, F. 1999. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsingremitting multiple sclerosis. J. Neuroimmunol. 94:212-221.
Lee, T. C., Malone, B., and Snyder, F. 1986. A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterization of 1-alkyl-2-lyso-sn-glycero-3-P: acetyl-CoA acetyltransferase in rat spleen. J. Biol. Chem. 261:5373-5377.
Baker, R. R. and Chang, H. Y. 1993. The potential for plateletactivating factor synthesis in brain: properties of cholinephosphotransferase and 1-alkyl-sn-glycero-3-phosphate acetyltransferase in microsomal fractions of immature rabbit cerebral cortex. Biochim. Biophys. Acta 1170:157-164.
Lee, T. C., Malone, B., and Snyder, F. 1988. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. J. Biol. Chem. 263:1755-1760.
Francescangeli, E. and Goracci, G. 1989. The de novo biosynthesis of platelet-activating factor in rat brain. Biochem. Biophys. Res. Comm. 161:107-112.
Goracci, G. and Francescangeli, E. 1991. Properties of PAFsynthesizing phosphocholinetransferase and evidence for lysoPAF acetyltransferase activity in rat brain. Lipids 26:986-991.
Woelk, H., Goracci, G., and Porcellati, G. 1974. The action of brain phospholipases A2 on purified, specifically labelled 1,2-diacyl-, 2-acyl-1-alk-1 '-enyl-and 2-acyl-1-alkyl-sn-glycero-3-phosphorylcholine. Hoppe-Seylers Zeitschrift fur Physiologische Chemie 355:75-81.
Rordorf, J., Uemura, Y., and Bonventre, J. V. 1991. Characterization of phospholipase A2 (PLA2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J. Neurosci. 11:1829-1836.
Blank, M. L., Smith, Z. L., Fitzgerald, V., and Snyder, F. 1995. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity. Biochim. Biophys. Acta 1254:295-301.
Baker, R. R. and Chang, H. Y. 1996. Alkylglycerophosphate acetyltransferase and lyso platelet activating factor acetyltransferase, two key enzymes in the synthesis of platelet activating factor, are found in neuronal nuclei isolated from cerebral cortex. Biochim. Biophys. Acta. 1302:257-263.
Lenihan, D. J. and Lee, T. C. 1984. Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. Biochem. Biophys. Res. Commun. 120:834-839.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, P. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem 193:265-275.
Goracci, G., Francescangeli, E., Horrocks, L. A., and Porcellati, G. 1983. The effect of CMP on the release of free fatty acids of rat brain in vitro. Neurochem. Res. 8:971-981.
Baker, R. R. and Chang, H. Y. 1998. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. Biochim. Biophys. Acta 1392:351-360.
Baker, R. R. and Chang, H. Y. 1998. Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor. Differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. Biochim. Biophys. Acta 1390:215-224.
Naraba, H., Ueno, A., Matsumoto, H., and Ohishi, S. 1996. Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils. Eur. J. Pharmacol. 302:117-121.
Remy, E., Lenoir, G., Houben, A., Vandesteene, C., and Remacle, J. 1989. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils. Biochim. Biophys. Acta 1005:87-92.
Goracci, G., Francescangeli, E., Horrocks, L. A., and Porcellati, G. 1981. The reverse reaction of cholinephosphotransferase in rat brain microsomes. A new pathway for degradation of phosphatidylcholine. Biochim. Biophys. Acta 664:373-379.
Onodera, H., Iijima, K., and Kogure, K. 1986. Mononucleotide metabolism in the rat brain after transient ischemia. J. Neurochem. 46:1704-1710.
Baker, R. R. and Chang, H. Y. 1994. MgATP inhibits the synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphate by microsomal acetyltransferase of immature rabbit cerebral cortex. Biochim Biophys. Acta 1213:27-33.
Baker, R. R. and Chang, H. Y. 1995. Fatty acyl-CoA inhibits 1-alkyl-sn-glycero-3-phosphate acetyltransferase in microsomes of immature rabbit cerebral cortex: Control of the first committed step in the de novo pathway of platelet-activating factor synthesis. J. Neurochem. 64:364-370.
Stoll, L. L., Yerram, N. R., and Spector, A. A. 1991. Effect of differentiation on platelet-activating factor metabolism in HL-60 cells. J. Cell Sci. 100:145-152.
Farooqui, A. A., Yang, H. C., Rosenberger, T. A., and Horrocks, L. A. 1997. Phospholipase A2 and its role in brain tissue. J. Neurochem. 69:889-901.
Farooqui, A. A. and Horrocks, L. A. 1998. Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer' disease. Biochemical Society Transactions 26:243-246.
Saluja, I., Song, D., Oregan, M. H., and Phillis, J. W. 1997. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci. Lett. 233:97-100.
Francescangeli, E., Domanska-Janik, K., and Goracci, G. 1996. Relative contribution of the de novo and remodeling pathways to the synthesis of platelet-activating factor in brain areas and during ischemia. J. Lipid Med. & Cell Signalling 14:89-98.
Domenech, C., Machado-De Domenech, E., Soling, H-D. 1987. Regulation of acetyl-CoA: 1-alkyl-sn-glycero-3-phosphocholineacetyltransferase (lysoPAF-acetyltransferase) in exocrine glands. Evidence for an activation via phosphorylation by calcium/ calmodulin-dependent protein kinase. J. Biol. Chem. 262:5671-5676.
Nieto, M. L., Velasco, S., and Sanchez-Crespo, M. 1988. Modulation of acetyl-CoA:1-alkyl-2-lyso-sn-glycero-3-phosphocholine (lysoPAF) acetyltransferase in human polymorphonuclears. The role of cyclic AMP-dependent and phospholipid sensitive, calcium-dependent protein kinases. J. Biol. Chem. 263: 4607-4611.
Hayashi, M., Imai, Y., and Oh-ishi, S. 1991. Phorbol ester stimulates PAF synthesis via the activation of protein kinase C in rat leukocytes. Lipids 26:1054-1059.
Nixon, A. B., O'Flaherty, J. T., Salyer, J. K., and Wylde, R. L. 1999. Acetyl-CoA:1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase is directly activated by p38 kinase. J. Biol. Chem. 274:5469-5473
Francescangeli, E., Porcellati, S., and Goracci, G. 1997. CMP-dependent degradation of Platelet-activating factor (PAF) by rat brain microsomes. Pages 1029-1034 in Telken, A. W., and Koff, J. (eds.), Neurochemistry, Plenum Press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francescangeli, E., Boila, A. & Goracci, G. Properties and Regulation of Microsomal PAF-Synthesizing Enzymes in Rat Brain Cortex. Neurochem Res 25, 705–713 (2000). https://doi.org/10.1023/A:1007523422825
Issue Date:
DOI: https://doi.org/10.1023/A:1007523422825